HUTCHMED (China) (HCM) Interest & Investment Income (2015 - 2021)

HUTCHMED (China)'s (HCM) quarterly Interest & Investment Income came in at $1.9 million in Q4 2021, up 385.97% on a QoQ basis from $385000.0 in Q2 2016.

HUTCHMED (China) (HCM) Interest & Investment Income (2015 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has 3 years of Interest & Investment Income data on file, last reported at $1.9 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 HUTCHMED (China) 9.45 Bn 9.45 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 1.87 Mn
Jun 30, 2016 385,000.00
Jun 30, 2015 379,000.00